Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 8.12 SEK -0.37% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

EV/FCFF
Enterprise Value to FCFF

-11.1
Current
-14
Median
3.8
Industry
Higher than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-11.1
=
Enterprise Value
1.4B SEK
/
FCFF
-129.3m SEK
All Countries
Close
Market Cap EV/FCFF
SE
Vicore Pharma Holding AB
STO:VICO
1.9B SEK -11.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -232 027.2
US
Abbvie Inc
NYSE:ABBV
352.5B USD 25.8
US
Amgen Inc
NASDAQ:AMGN
174.8B USD 35.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD -88.9
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD 11.5
US
Epizyme Inc
F:EPE
94.1B EUR -483.4
AU
CSL Ltd
ASX:CSL
137.9B AUD 66.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD 25.3
US
Seagen Inc
F:SGT
39.3B EUR -58.4
NL
argenx SE
XBRU:ARGX
33.2B EUR -99.8
 
SE
Vicore Pharma Holding AB
STO:VICO
Average EV/FCFF: 33
Negative Multiple: -11.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -232 027.2
US
Abbvie Inc
NYSE:ABBV
25.8
US
Amgen Inc
NASDAQ:AMGN
35.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -88.9
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -483.4
AU
CSL Ltd
ASX:CSL
66.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -99.8

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More